https://www.selleckchem.com/pr....oducts/ipilimumab.ht
The sensitivity of the assays were 84.7 (95 %CI 80.6-88.1), 82.6 (95 %CI 78.3-86.2) and 75.7 (95 %CI 71.0-79.9) respectively for RBD, LIAISON and Kavach. Kavach and the in-house RBD ELISA showed a specificity of 99.5 % and 100 %, respectively. The RBD and LIAISON (S1/S2) assays showed high agreement (94.7 %; 95 %CI 92.0, 96.6) and were able to correctly identify more positive sera/plasma than Kavach. Independent comparisons support the evaluation of performance characteristics of immunoassays. All three assays are suitable for serosu
Like
Comment
Share
